Literature DB >> 27198055

Pharmacologic, Pharmacokinetic, and Clinical Assessment of Illicitly Used γ-Hydroxybutyrate.

C Michael White1.   

Abstract

γ-Hydroxybutyrate (GHB) is a common drug of abuse and poses important health risks to users in the form of respiratory, cardiovascular, mental, or traumatic adverse events. GHB has non-dose-proportional effects and pharmacologic effects such as sedation and retrograde amnesia, which can incapacitate people targeted for assault. It has Krebs cycle metabolism, rapid clearance, relative hydrophilicity, and unique drug interactions. Promptly seeking medical attention during intentional or inadvertent overdose is critical to survival, as is prompt supportive care once medical personnel are alerted. People drugged before assault also need to promptly notify authorities because the period to detect the drug in the urine or blood is brief and the ultimate metabolites are carbon dioxide and water. After acute treatment has passed, withdrawal could be severe in chronic abusers that could harm the patient directly or drive them back into reuse.
© 2016, The American College of Clinical Pharmacology.

Entities:  

Keywords:  adverse events; pharmacology; withdrawal; γ-hydroxybutyrate

Mesh:

Substances:

Year:  2016        PMID: 27198055     DOI: 10.1002/jcph.767

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  6 in total

1.  Treatment of γ-Hydroxybutyric Acid and γ-Butyrolactone Overdose with Two Potent Monocarboxylate Transporter 1 Inhibitors, AZD3965 and AR-C155858.

Authors:  Kristin E Follman; Marilyn E Morris
Journal:  J Pharmacol Exp Ther       Date:  2019-04-22       Impact factor: 4.030

Review 2.  γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.

Authors:  Melanie A Felmlee; Bridget L Morse; Marilyn E Morris
Journal:  AAPS J       Date:  2021-01-08       Impact factor: 4.009

3.  Inpatient Gamma-Hydroxybutyrate Detoxification: A Case Report Describing Day-to-day Therapeutic Management.

Authors:  Louis von Theobald; Morgane Rousselet; Jennyfer Cholet; Hélène Debar; David Boels; Caroline Victorri-Vigneau; Marie Grall-Bronnec
Journal:  J Addict Med       Date:  2017 May/Jun       Impact factor: 3.702

4.  Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.

Authors:  Evangelia Liakoni; Fabio Walther; Christian H Nickel; Matthias E Liechti
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-08-31       Impact factor: 2.953

Review 5.  Metabolic Alterations Associated with γ-Hydroxybutyric Acid and the Potential of Metabolites as Biomarkers of Its Exposure.

Authors:  Suryun Jung; Suji Kim; Yujin Seo; Sooyeun Lee
Journal:  Metabolites       Date:  2021-02-10

Review 6.  Toxicological Characterization of GHB as a Performance-Enhancing Drug.

Authors:  Arianna Giorgetti; Francesco Paolo Busardò; Raffaele Giorgetti
Journal:  Front Psychiatry       Date:  2022-04-18       Impact factor: 5.435

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.